−0.2422EUR
−57.15 MEUR
5.47 MEUR
251.67 M
About OCUGEN INC. DL-,001
Sector
CEO
Shankar Musunuri
Headquarters
Malvern
Website
Employees (FY)
65
Founded
2013
FIGI
BBG007PQLLW4
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange OCUGEN INC. DL-,001 stocks are traded under the ticker 2H51.
OCUGEN INC. DL-,001 is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
2H51 earnings for the last quarter are −0.06 EUR per share, whereas the estimation was −0.07 EUR resulting in a 14.29% surprise. The estimated earnings for the next quarter are −0.05 EUR per share. See more details about OCUGEN INC. DL-,001 earnings.
Yes, you can track OCUGEN INC. DL-,001 financials in yearly and quarterly reports right on TradingView.
2H51 net income for the last quarter is −9.94 M EUR, while the quarter before that showed −13.40 M EUR of net income which accounts for 25.81% change. Track more OCUGEN INC. DL-,001 financial stats to get the full picture.
No, 2H51 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2H51 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OCUGEN INC. DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 65.00 employees. See our rating of the largest employees — is OCUGEN INC. DL-,001 on this list?
We've gathered analysts' opinions on OCUGEN INC. DL-,001 future price: according to them, 2H51 price has a max estimate of 7.48 EUR and a min estimate of 4.67 EUR. Read a more detailed OCUGEN INC. DL-,001 forecast: see what analysts think of OCUGEN INC. DL-,001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OCUGEN INC. DL-,001 EBITDA is −61.12 M EUR, and current EBITDA margin is −1.07 K%. See more stats in OCUGEN INC. DL-,001 financial statements.